pramipexole has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mantovani, E; Tamburin, S | 1 |
1 other study(ies) available for pramipexole and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
D2/D3 Receptor Agonism: Paving the Way for a New Therapeutic Target for Taste Disorders in Parkinson's Disease and Other Conditions?
Topics: Aged; Benzothiazoles; COVID-19; Dopamine; Dopamine Agonists; Healthy Volunteers; Humans; Parkinson Disease; Post-Acute COVID-19 Syndrome; Pramipexole; Quality of Life; Receptors, Dopamine D3; Taste; Taste Disorders | 2022 |